ADBE
66
4
GOOGL
67
3
XYL
43
-4
NWL
32
4
T
45
3
NOV
37
-2
SLG
71
-4
AEE
46
11
BAX
41
3
FLR
36
-3
AMGN
47
-13
AMP
73
-2
HBAN
33
2
FOX
30
2
AVB
72
3
JPM
60
-2
VMC
57
3
DNB
36
2
DRI
61
-2
ADT
55
25
ADBE
66
4
GOOGL
67
3
XYL
43
-4
NWL
32
4
T
45
3
NOV
37
-2
SLG
71
-4
AEE
46
11
BAX
41
3
FLR
36
-3
AMGN
47
-13
AMP
73
-2
HBAN
33
2
FOX
30
2
AVB
72
3
JPM
60
-2
VMC
57
3
DNB
36
2
DRI
61
-2
ADT
55
25
Financhill
Back

Avista Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
32

AVA
Avista

Last Price:
33.70
Seasonality Move:
-0.44%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
32
Avista (AVA) is a Sell

Is Avista a Buy, Sell or Hold?

  • The current Avista [AVA] share price is $33.70. The Score for AVA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • AVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AVA Stock Price Chart

What is Avista's stock price today?

  • The Avista share price today is $33.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVA is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

AVA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.76 Sell
Relative Strength Index (14 RSI): 23.65 Sell
Chaikin Money Flow: -532471 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.48 - 37.44) Sell
Bollinger Bands (100): (33.33 - 36.57) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

AVA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.28 Sell
20-day SMA: 35.4 Sell
50-day SMA: 36.03 Sell
200-day SMA: 34.49 Sell
8-day EMA: 34.3 Sell
20-day EMA: 35.18 Sell
50-day EMA: 35.6 Sell
200-day EMA: 35.61 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Avista Earnings Growth & AVA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.23 per share, an increase this year of $0.15 per share, and an increase next year of $0.19 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Avista Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):